Study S000056

A European Multi-centre, Retrospective, Non-interventional Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02754817
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 611
Start: 2016-04-26
Primary completion: 2016-10-20
Lead sponsor: Novo Nordisk A/S
Conditions: Diabetes; Diabetes Mellitus, Type 2
Interventions: DRUG:insulin degludec/liraglutide
Results posted: FALSE
Secondary identifiers: OTHER:U1111-1176-6538

Registered primary outcomes

Change in HbA1c (Hemoglobin A1c) [week 0, week 26]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0009627	Use and effectiveness of a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) in a real-world population with type 2 diabetes: Results from a European, multicentre, retrospective chart review study. Price H, Diabetes, obesity & metabolism	2018	Nonrandomized study	PMID 29205856 DOI	registry reference RESULT:29205856